Role of Fibroblast Growth Factor Receptor 2 (FGFR2) in Corneal Stromal Thinning

被引:7
作者
Joseph, Roy [1 ]
Boateng, Akosua [1 ]
Srivastava, Om P. [1 ]
Pfister, Roswell R. [2 ]
机构
[1] Univ Alabama Birmingham, Sch Optometry, Dept Optometry & Vis Sci, Birmingham, AL USA
[2] Eye Res Fdn, Birmingham, AL USA
关键词
cornea; fibroblast growth factor receptor-2; conditional knockout mice; keratocytes; stromal thinning; corneal hydrops; keratoconus; ACTIVATED PROTEIN-KINASE; CELL-DEATH; KERATOCYTE APOPTOSIS; MATRIX COMPONENTS; HYDROPS; EXPRESSION; CANCER; FIBROBLAST-GROWTH-FACTOR-RECEPTOR-2; PROTEOGLYCAN; ENDOTHELIUM;
D O I
10.1167/iovs.64.12.40
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To determine the role of fibroblast growth factor receptor 2 (FGFR2)-mediated signaling in keratocytes during corneal development, a keratocyte-specific FGFR2knockout (named FGFR2-cKO) mouse model was generated, and its phenotypic characteristics were determined. METHODS. A FGFR2cKO mouse model was generated by the following method: FGFR2 flox mice were crossed with the inducible keratocyte specific-Cre mice (Kera-rtTA/tet-O-Cre). Both male and female FGFR2cKO- and control mice (1 to 3-months-old) were analyzed for changes in corneal topography and pachymetry maps using the optical coherence tomography (OCT) method. The comparative TUNEL assay and immunohistochemical analyses were performed using corneas of FGFR2cKO and control mice to determine apoptotic cells, and expression of collagen-1 and fibronectin. Transmission electron microscopic analysis was conducted to determine collagen structures and their diameters in corneas of FGFR2cKO and control mice. RESULTS. OCT-analyses of corneas of FGFR2cKO mice (n = 24) showed localized central thinning and an increased corneal steepness compared to control mice (n = 23). FGFR2cKO mice further showed a decreased expression in collagen-1, decreased collagen diameters, acute corneal hydrops, an increased fibronectin expression, and an increased number of TUNEL-positive cells suggesting altered collagen structures and keratocytes' apoptosis in the corneas of FGFR2cKO mice compared to control mice. CONCLUSIONS. The FGFR2cKO mice showed several corneal phenotypes (as described above in the results) that are also exhibited by the human keratoconus corneas. The results suggested that the FGFR2cKO mouse model serves to elucidate not only the yet unknown role of FGFR2-mediated signaling in corneal physiology but also serves as a model to determine molecular mechanism of human keratoconus development.
引用
收藏
页数:15
相关论文
共 50 条
[41]   Antiangiogenic Activity of Alofanib, an Allosteric Inhibitor of Fibroblast Growth Factor Receptor 2 [J].
Khochenkov, D. A. ;
Solomko, E. Sch. ;
Peretolchina, N. M. ;
Ryabaya, O. O. ;
Stepanova, E. V. .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 160 (01) :84-87
[42]   The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study [J].
Bodner-Adler, Barbara ;
Mayerhofer, Klaus ;
Czerwenka, Klaus ;
Kimberger, Oliver ;
Koelbl, Heinz ;
Bodner, Klaus .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2016, 207 :62-67
[43]   FGFR2 mutations are rare across histologic subtypes of ovarian cancer [J].
Byron, Sara A. ;
Gartside, Michael G. ;
Wellens, Candice L. ;
Goodfellow, Paul J. ;
Birrer, Michael J. ;
Campbell, Ian G. ;
Pollock, Pamela M. .
GYNECOLOGIC ONCOLOGY, 2010, 117 (01) :125-129
[44]   MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2 [J].
Fu, Y-T. ;
Zheng, H. -B. ;
Zhang, D. -Q. ;
Zhou, L. ;
Sun, H. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (11) :3430-3438
[45]   Ascorbic acid attenuates cell stress by activating the fibroblast growth factor 21/fibroblast growth factor receptor 2/adiponectin pathway in HepG2 cells [J].
Gu, Xinqian ;
Luo, Xiao ;
Wang, Yanxin ;
He, Zhangya ;
Li, Xiaomin ;
Wu, Kunjin ;
Zhang, Yifan ;
Yang, Yafeng ;
Ji, Jing ;
Luo, Xiaoqin .
MOLECULAR MEDICINE REPORTS, 2019, 20 (03) :2450-2458
[46]   Elucidating the Role of Wildtype and Variant FGFR2 Structural Dynamics in (Dys)Function and Disorder [J].
Lian, Yiyang ;
Bodian, Dale ;
Shehu, Amarda .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
[47]   Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations [J].
Lee, Patrick C. ;
Hendifar, Andrew ;
Osipov, Arsen ;
Cho, May ;
Li, Daneng ;
Gong, Jun .
CANCERS, 2021, 13 (07)
[48]   Targeting fibroblast growth factor receptor (FGFR) with inhibitors in head and neck cancers: Their roles, mechanisms and challenges [J].
Luo, Daowen ;
Kumfu, Sirinart ;
Chattipakorn, Nipon ;
Chattipakorn, Siriporn C. .
BIOCHEMICAL PHARMACOLOGY, 2025, 235
[49]   Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer [J].
Saridogan, Turcin ;
Akcakanat, Argun ;
Zhao, Ming ;
Evans, Kurt W. ;
Yuca, Erkan ;
Scott, Stephen ;
Kirby, Bryce P. ;
Zheng, Xiaofeng ;
Ha, Min Jin ;
Chen, Huiqin ;
Ng, Patrick K. S. ;
DiPeri, Timothy P. ;
Mills, Gordon B. ;
Ahnert, Jordi Rodon ;
Damodaran, Senthil ;
Meric-Bernstam, Funda .
SCIENTIFIC REPORTS, 2023, 13 (01)
[50]   The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer? [J].
Massabeau, Carole ;
Sigal-Zafrani, Brigitte ;
Belin, Lisa ;
Savignoni, Alexia ;
Richardson, Marion ;
Kirova, Youlia M. ;
Cohen-Jonathan-Moyal, Elizabeth ;
Megnin-Chanet, Frederique ;
Hall, Janet ;
Fourquet, Alain .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) :259-266